We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Koninklijke Philips NV | EU:PHIA | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.275 | -1.40% | 19.345 | 19.34 | 19.35 | 19.65 | 19.325 | 19.595 | 905,348 | 15:08:06 |
From Apr 2019 to Apr 2024
By Jaime Llinares Taboada
Koninklijke Philips NV said Friday that it hasn't raised the prices of its ventilators in the U.S. to benefit from the coronavirus pandemic.
The Dutch medical-technology company said that it doesn't recognize the conclusions of a report released on Friday by the U.S. House of Representatives Subcommittee on Economic and Consumer Policy.
The report claims that an order made in 2014 for more than 10,000 Trilogy ventilators by June 2019 was renegotiated earlier this year under new terms at almost five times the price of the previous contract.
The report also says that a second contact for 43,000 Trilogy EV300 ventilators was entered into on April 7 at $15,000 each.
"I would like to make clear that at no occasion, Philips has raised prices to benefit from the crisis situation," the company's Chief Executive Frans van Houten said.
Write to Jaime Llinares Taboada at jaime.llinares@wsj.com; @JaimeLlinaresT
(END) Dow Jones Newswires
July 31, 2020 10:35 ET (14:35 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Koninklijke Philips NV Chart |
1 Month Koninklijke Philips NV Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
